Physical Activity and Sedentary Behavior During Pregnancy (PREGMOUV)

September 23, 2024 updated by: University Hospital, Clermont-Ferrand

Care Pathway Organization in Order to Increase Physical Activity Levels and Limit Sedentary Behavior During Pregnancy: a Randomized Controlled Trial

Our main objective is to evaluate the intervention that best enables women's adherence to physical activity (PA).

Our hypothesis is that identifying types of interventions suitable for pregnant women (in-person PA sessions, videoconferences or mixed format) could help improve their PA level and simultaneously reduce their sedentary behavior (SB).

Study Overview

Detailed Description

PA has beneficial effects on physical, psychological, and social health, and its regular practice helps to prevent numerous chronic diseases. During pregnancy, PA also has many benefits for women's physical condition, weight gain, gestational hypertension, lower back and pelvic pain, and postpartum depressive symptoms and may also reduce fetal macrosomia and positively affect neurogenesis, language development, memory, and other learning-associated cognitive functions. (CNSF 2021). PA is thus recommended to all pregnant women for 150 to 180 minutes a week, adapted to their health status, physical condition, and course of pregnancy. It is also recommended that women limit their Sedentary Behaviour (SB) (to ≤7 waking h/day) during pregnancy.

No French study has assessed the impact of a PA program during pregnancy, and no published study has proposed videoconference PA sessions during pregnancy. Pregnant women's adherence to PA is a limiting factor found in many interventional studies. Possible changes in maternal behavior in practicing PA and reducing SB during pregnancy could also favorably affect the health of mother and child and thus subsequent PA. Given PA's many benefits and SB's harmful effects during pregnancy, assessing programs that enable pregnant women to both increase PA levels and reduce SB seems pertinent and valuable.

Study Type

Interventional

Enrollment (Estimated)

630

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Pregnant women of more of 18 years and who are being monitored for pregnancy in the Clermont-Ferrand metropolitan area,
  • Planned to give birth in a maternity unit localized in Clermont-Ferrand metropolitan area (CHU Estaing or Clinique de la Chataigneraie),
  • Agreeing to be randomized, to follow the physical activity program offered in the Clermont-Ferrand metropolitan area, and to follow up as part of the study,
  • Able to give informed consent to participate in the research,
  • Affiliated to a social security scheme
  • And between 14+0d and 21+6d weeks of gestation.

Non inclusion Criteria:

  • Women under guardianship, curators, deprived of liberty or under court protection,
  • With a history of recurrent miscarriage,
  • Presenting a multiple pregnancy,
  • Hemoglobinemia <9g/dL or symptomatic anemia,
  • Presenting eating disorders or a BMI ≤ 18.5 or a BMI ≥ 40,
  • With orthopedic limitations,
  • Presenting cardiovascular or pulmonary disease,
  • Uncontrolled thyroid disease,
  • Presenting a high level of smoking,
  • With significant health problems,
  • Premature rupture of membranes,
  • Premature labor during this pregnancy or a history of at least 2 premature births,
  • Persistent vaginal bleeding,
  • Cervical incompetence,
  • Evidence of intrauterine growth restriction,
  • Uncontrolled epilepsy,
  • Diabetes (previous or gestational, diagnosed in the 1st trimester) or chronic hypertension,
  • Or having a planned home birth.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: A - Free PA practice
The women in group A (control group) will receive the usual care provided for any pregnancy, i.e. personalised information on physical activity and sedentary behaviour, with the provision of information booklets. They will be free to exercise during their pregnancy
Experimental: B
In-person supervised PA sessions
Group B women will have access to a weekly program of 3 face-to-face PA sessions. The face-to-face sessions will be offered at one or more locations in the Clermont-Ferrand area, depending on the number of groups taking part. They will also be offered at one or more times depending on the number of groups. Locations and times will be specified on the online booking software. Women can only register for 3 sessions per week.
Experimental: C
Interactive videoconference PA sessions
Women in Group C will have access to a weekly program of 3 PA sessions via interactive videoconferencing. These sessions will have the same format as the face-to-face sessions with visualization of the APA professional, visualization of the participants (who can also choose to be masked). The PA professional will also see the participants, so he or she can correct positions and give individualized advice at any time. Schedules will be specified on the online booking software with the videoconference link. Women can only register for 3 sessions per week.
Experimental: D
In person and by videoconference (mixed format) PA sessions
Women in Group D will have access to a weekly program of 3 mixed-format PA sessions, with 2 interactive distance learning sessions and 1 in-person session. The in-person sessions will be offered at one or more locations in the Clermont-Ferrand area, depending on the number of groups taking part. Locations and times will be specified on the online booking software. Women can only register for 1 face-to-face session per week. The other 2 sessions will be offered via interactive videoconferencing. These sessions will have the same format as the in-person sessions, with visualization of the APA professional, visualization of the participants. The APA professional will also see the participants, so he or she can correct positions and give individualized advice at any time. Schedules will be specified on the online booking software with the videoconference link. Women can only register for 2 videoconference's sessions per week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Women's adherence to PA at the end of the second trimester
Time Frame: between 24 and 30 weeks of gestation
measurement of the PA level, measured by accelerometer, expressed in MET.minutes/week by wearing a tri-axial accelerometer on the hip
between 24 and 30 weeks of gestation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
women's adherence in terms of reduction of Sedentary Behaviors at the end of the 2nd trimester
Time Frame: between 24 and 30 weeks of gestation
measurement of sedentary time (defined as a state of wakefulness characterized by an energy expenditure less than or equal to 1.5 METs) between getting up and going to bed using a tri-axial hip accelerometer
between 24 and 30 weeks of gestation
Women's participation at PA sessions
Time Frame: After 39 weeks of gestation, end of planned participation in sessions
For women in groups B, C and D, rate of sessions completed on the number of eligible sessions according to their randomization group and the socio-demographic criteria
After 39 weeks of gestation, end of planned participation in sessions
Pregnancy and Postpartum Evolution of PA Time
Time Frame: at 4 distinct times: between 24+0d and 30+0d weeks of gestation, between 32+0d and 37+6d weeks of gestation, between 6 and 10 weeks postpartum and between 20 and 24 weeks postpartum
PA time measured with a tri-axial accelerometer at the hip
at 4 distinct times: between 24+0d and 30+0d weeks of gestation, between 32+0d and 37+6d weeks of gestation, between 6 and 10 weeks postpartum and between 20 and 24 weeks postpartum
Evolution in sedentary behavior during pregnancy and postpartum
Time Frame: at 4 distinct times: between 24 and 30 weeks of gestation, between 32+0day and 37+6day weeks of gestation, between 6 and 10 weeks postpartum and between 20 and 24 weeks postpartum
sedentary time (defined as wakefulness characterized by an energy expenditure less than or equal to 1.5 METs) between getting up and going to bed will be compared according to each intervention modality. Sedentary behavior will be measured by wearing a tri-axial accelerometer on the hip
at 4 distinct times: between 24 and 30 weeks of gestation, between 32+0day and 37+6day weeks of gestation, between 6 and 10 weeks postpartum and between 20 and 24 weeks postpartum
Women's perception of the determinants of their level of physical activity and sedentary behaviour
Time Frame: during the 31 days after at the inclusion in the study and between 35 and 39 weeks of gestation
Qualitative study by means of semi-structured telephone interviews with a minimum of 100 women, i.e. a minimum of 25 women per group, a number to be adapted according to the data saturation that will be obtained
during the 31 days after at the inclusion in the study and between 35 and 39 weeks of gestation
Impact of physical activity on maternal antenatal morbidity
Time Frame: At delivery
occurrence of maternal pathology during pregnancy (gestational arterial hypertension [PAS ≥ 140 mm Hg and a PAD ≥ 90 mm Hg occurring after 20 weeks of gestation] and/or, pre-eclampsia [hypertension with albuminuria > 0.3g/L per 24 hours] and/or gestational diabetes diagnosed by orally induced hyperglycaemia after 23 SA)
At delivery
Impact of sedentary behaviour on maternal antenatal morbidity
Time Frame: At delivery
occurrence of maternal pathology during pregnancy (gestational arterial hypertension [PAS ≥ 140 mm Hg and a PAD ≥ 90 mm Hg occurring after 20 weeks of gestation] and/or, pre-eclampsia [hypertension with albuminuria > 0.3g/L per 24 hours] and/or gestational diabetes diagnosed by orally induced hyperglycaemia after 23 SA)
At delivery
Impact of physical activity on perpartum maternal morbidity
Time Frame: 24 hours after delivery
A composite criterion: "occurrence of 3rd or 4th degree perineal lesions and/or occurrence of immediate postpartum haemorrhage (blood loss > 500mL in the 24 hours after delivery)"
24 hours after delivery
Impact of sedentary behaviour on perpartum maternal morbidity
Time Frame: 24 hours after delivery
A composite criterion: "occurrence of 3rd or 4th degree perineal lesions and/or occurrence of immediate postpartum haemorrhage (blood loss > 500mL in the 24 hours after delivery)"
24 hours after delivery
Impact of physical activity on postpartum maternal morbidity
Time Frame: 6 months postpartum
: presence of a depressive state assessed by the Edinburgh Depression Scale (EPDS) (with a discriminant threshold of the EPDS ≥ 11)
6 months postpartum
Impact of sedentary behaviour on postpartum maternal morbidity
Time Frame: 6 months postpartum
: presence of a depressive state assessed by the Edinburgh Depression Scale (EPDS) (with a discriminant threshold of the EPDS ≥ 11)
6 months postpartum
Impact of physical activity on the experience of childbirth
Time Frame: 4 weeks postpartum
Evaluation using the Questionnaire for Assessing the Childbirth Experience (QACE)
4 weeks postpartum
Impact of sedentary behaviour on the experience of childbirth
Time Frame: 4 weeks postpartum
Evaluation using the Questionnaire for Assessing the Childbirth Experience (QACE)
4 weeks postpartum
Impact of physical activity on the quality of life of pregnant women at the end of the 2nd trimester of pregnancy
Time Frame: between 24 and 30 weeks of gestation
Score obtained in the WHOQOL-Bref questionnaire
between 24 and 30 weeks of gestation
Impact of sedentary behaviour on the quality of life of pregnant women at the end of the 2nd trimester of pregnancy
Time Frame: between 24 and 30 weeks of gestation
Score obtained in the WHOQOL-Bref questionnaire
between 24 and 30 weeks of gestation
Impact of physical activity on the quality of life of pregnant women at the end of the 3rd trimester of pregnancy
Time Frame: between 32 and 37 SA+6day weeks of gestation
Score obtained in the WHOQOL-Bref questionnaire
between 32 and 37 SA+6day weeks of gestation
Impact of sedentary behaviour on the quality of life of pregnant women at the end of the 3rd trimester of pregnancy
Time Frame: between 32 and 37 SA+6day weeks of gestation
Score obtained in the WHOQOL-Bref questionnaire
between 32 and 37 SA+6day weeks of gestation
Impact of physical activity on the quality of life of pregnant women at 2 months postpartum
Time Frame: between 6 and 10 weeks postpartum
Score obtained from the WHOQOL-Bref questionnaire
between 6 and 10 weeks postpartum
Impact of sedentary behaviour on the quality of life of pregnant women at 2 months postpartum
Time Frame: between 6 and 10 weeks postpartum
Score obtained from the WHOQOL-Bref questionnaire
between 6 and 10 weeks postpartum
Impact of physical activity on the quality of life of pregnant women at 6 months postpartum
Time Frame: between 20 and 24 weeks postpartum
Score obtained from the WHOQOL-Bref questionnaire
between 20 and 24 weeks postpartum
Impact of sedentary behaviour on the quality of life of pregnant women at 6 months postpartum
Time Frame: between 20 and 24 weeks postpartum
Score obtained from the WHOQOL-Bref questionnaire
between 20 and 24 weeks postpartum
Impact of physical activity on the occurrence of urinary incontinence in the 2nd trimester of pregnancy
Time Frame: between 24 and 30 weeks of gestation
ICIQ-SF questionnaire score - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
between 24 and 30 weeks of gestation
Impact of sedentary behaviour on the occurrence of urinary incontinence in the 2nd trimester of pregnancy
Time Frame: between 24 and 30 weeks of gestation
ICIQ-SF questionnaire score - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
between 24 and 30 weeks of gestation
Impact of physical activity on the occurrence of urinary incontinence in the 3rd trimester of pregnancy
Time Frame: between 32 and 37 SA+6day weeks of gestation
ICIQ-SF questionnaire score - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
between 32 and 37 SA+6day weeks of gestation
Impact of sedentary behaviour on the occurrence of urinary incontinence in the 3rd trimester of pregnancy
Time Frame: between 32 and 37 SA+6day weeks of gestation
ICIQ-SF questionnaire score - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
between 32 and 37 SA+6day weeks of gestation
Impact of physical activity on the occurrence of urinary incontinence at 6 months postpartum
Time Frame: between 20 and 24 weeks postpartum
Score on the ICIQ-SF questionnaire - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
between 20 and 24 weeks postpartum
Impact of sedentary behaviour on the occurrence of urinary incontinence at 6 months postpartum
Time Frame: between 20 and 24 weeks postpartum
Score on the ICIQ-SF questionnaire - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
between 20 and 24 weeks postpartum
Impact of physical activity on sexual quality of life
Time Frame: between 20 and 24 weeks postpartum
Score on the FSFI Female Sexual Function Index questionnaire
between 20 and 24 weeks postpartum
Impact of sedentary behaviour on sexual quality of life
Time Frame: between 20 and 24 weeks postpartum
Score on the FSFI Female Sexual Function Index questionnaire
between 20 and 24 weeks postpartum
Impact of physical activity on early neonatal morbidity
Time Frame: At delivery
a composite criterion: "Apgar score <7 at 5 min and/or arterial pH <7.10 and/or transfer and/or intra-hospital transfer to a neonatal unit"
At delivery
Impact of sedentary behaviour on early neonatal morbidity
Time Frame: At delivery
a composite criterion: "Apgar score <7 at 5 min and/or arterial pH <7.10 and/or transfer and/or intra-hospital transfer to a neonatal unit"
At delivery
Impact of physical activity on the newborn's birth weight
Time Frame: At delivery
occurence of large for gestational age newborns (birth weight greater than the 95th percentile according to gestational age according to Audipog curves)
At delivery
Impact of sedentary behaviour on the newborn's birth weight
Time Frame: At delivery
occurence of large for gestational age newborns (birth weight greater than the 95th percentile according to gestational age according to Audipog curves)
At delivery
Cost-effectiveness analysis from the point of view of health insurance of the proposed intervention methods
Time Frame: Data collected during the pregnancy and until 2 month of post-partum
Cost-effectiveness incremental study (including modelling of the gains linked to the reduction in C-section)
Data collected during the pregnancy and until 2 month of post-partum
cost-utility study analysis from the point of view of health insurance of the proposed intervention methods
Time Frame: Data collected during the pregnancy and until 6 month of post-partum
Cost-utility study (based on the usefulness felt by women) from the point of view of health insurance using the EQ5D-5L (5 Level Euroqol 5 Dimensions) and a mapping analysis of the WHOQOL-Bref
Data collected during the pregnancy and until 6 month of post-partum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2024

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2027

Study Registration Dates

First Submitted

August 26, 2024

First Submitted That Met QC Criteria

September 3, 2024

First Posted (Actual)

September 5, 2024

Study Record Updates

Last Update Posted (Actual)

September 24, 2024

Last Update Submitted That Met QC Criteria

September 23, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RBHP 2024 BARASINSKI
  • 2024-A00459-38 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnant Woman

Clinical Trials on In person PA sessions

Subscribe